A clinical study to determine the safety and effectiveness of intracoronary infusion of autologous c-kit-positive cardiac stem cells in Japanese patients with ischemic cardiomyopathy.

Phase 1

• Conditions: Chronic ischemic heart failure; Heart Failure

• Registration Number: JPRN-jRCTb030200001
• Lead Sponsor: Hosoda Toru

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-03-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 6

Inclusion Criteria

Adult with ability to provide informed consent.
Left ventricular ejection fraction less than 40%.
Scheduled for elective surgical revascularization within 2 months.

Exclusion Criteria

Positive for HBs-Ag, HCV-Ab, HIV-Ab, or tests for syphilis.
Diabetic HbA1c greater than 8.5%.
Pregnant women.
Scheduled for additional interventions including ventriculoplasty.

Study & Design

• Study Type: Interventional
• Study Design: Not specified